Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Rubins

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Chest|November 1, 1996
Etiology and prognostic significance of eosinophilic pleural effusions. A prospective studyJ B Rubins, H B Rubins
Journal of General Internal Medicine|March 1, 1990
Complications of care in a medical intensive care unitH B Rubins, M A Moskowitz
The American Journal of Cardiology|September 29, 2000
Conclusions from the VA-HIT studyH B Rubins, S J Robins
Journal of Clinical Pharmacology|August 1, 1995
Effects of phenytoin on plasma high-density lipoprotein cholesterol levels in men with low levels of high-density lipoprotein cholesterolC Goerdt, M Keith, H B Rubins
The American Journal of Cardiology|September 1, 1996
The Veterans Affairs High-Density Lipoprotein Intervention Trial: baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol. Veterans Affairs Cooperative Studies Program High-Density Lipoprotein Intervention Trial Study GroupH B Rubins, S J Robins, D Collins
European Heart Journal|August 5, 2000
The VA HDL intervention trial: clinical implicationsH B Rubins, D Collins, S J Robins
Thrombosis Research|August 1, 1995
Can phenytoin lower plasma fibrinogen concentrations?C Goerdt, H B Rubins, W Swaim, et al.
Archives of Internal Medicine|March 1, 1990
The medical day hospital. A new concept in ambulatory medical educationB G Fincke, S A Gaehde, H B Rubins
Atherosclerosis|September 21, 2000
Cardiovascular risk changes after lipid lowering medications: are they predictable?C R Sirtori, L Calabresi, R Marchioli, et al.
Archives of Internal Medicine|December 1, 1992
Distribution of lipid phenotypes in community-living men with coronary heart disease. High prevalence of isolated low levels of high-density lipoprotein cholesterolH B Rubins, G Schectman, T J Wilt, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Chest|November 1, 1996
Etiology and prognostic significance of eosinophilic pleural effusions. A prospective studyJ B Rubins, H B Rubins
Journal of General Internal Medicine|March 1, 1990
Complications of care in a medical intensive care unitH B Rubins, M A Moskowitz
The American Journal of Cardiology|September 29, 2000
Conclusions from the VA-HIT studyH B Rubins, S J Robins
Journal of Clinical Pharmacology|August 1, 1995
Effects of phenytoin on plasma high-density lipoprotein cholesterol levels in men with low levels of high-density lipoprotein cholesterolC Goerdt, M Keith, H B Rubins
The American Journal of Cardiology|September 1, 1996
The Veterans Affairs High-Density Lipoprotein Intervention Trial: baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol. Veterans Affairs Cooperative Studies Program High-Density Lipoprotein Intervention Trial Study GroupH B Rubins, S J Robins, D Collins
European Heart Journal|August 5, 2000
The VA HDL intervention trial: clinical implicationsH B Rubins, D Collins, S J Robins
Thrombosis Research|August 1, 1995
Can phenytoin lower plasma fibrinogen concentrations?C Goerdt, H B Rubins, W Swaim, et al.
Archives of Internal Medicine|March 1, 1990
The medical day hospital. A new concept in ambulatory medical educationB G Fincke, S A Gaehde, H B Rubins
Atherosclerosis|September 21, 2000
Cardiovascular risk changes after lipid lowering medications: are they predictable?C R Sirtori, L Calabresi, R Marchioli, et al.
Archives of Internal Medicine|December 1, 1992
Distribution of lipid phenotypes in community-living men with coronary heart disease. High prevalence of isolated low levels of high-density lipoprotein cholesterolH B Rubins, G Schectman, T J Wilt, et al.
Pageof 4